Status:
COMPLETED
VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection
Lead Sponsor:
University of Lisbon
Collaborating Sponsors:
Cardiovascular Centre of Universidade de Lisboa (CCUL)
Faculty of Medicine of Universidade de Lisboa (FMUL)
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Vitamin D deficiency has been linked to hypertension, autoimmune, infectious and cardiovascular diseases which are risk factors for COVID-19. Moreover, COVID-19 patients have a very high prevalence of...
Detailed Description
Collected data from Turin University indicate that hospitalized patients have a very high prevalence of hypovitaminosis D. Reports from China and Italy show that hypertension presents an increased ris...
Eligibility Criteria
Inclusion
- Adults of 18 years and above.
- COVID-19 patients admitted with mild to severe disease (admission to isolation room) or critical patients (admission to ICU).
- Available to comply with study protocol and sign informed consent.
Exclusion
- Patients diagnosed with COVID-19 not admitted to hospital.
- Patients unable to provide informed consent.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
517 Patients enrolled
Trial Details
Trial ID
NCT04370808
Start Date
August 1 2020
End Date
January 31 2021
Last Update
April 28 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Center at Universidade de Lisboa
Lisbon, Lisbon District, Portugal, 1649-032
2
Centro Hospitalar Universitário Lisboa Norte
Lisbon, Lisbon District, Portugal, 1649-032
3
Centro Hospitalar de São João
Porto, Portugal, 4200-319